Food for afterthought: Reflections from 2 implantable cardioverter defibrillator trials

Archives of Internal Medicine

Volumn 164, Issue 17, 2004, Pages 1835-1839

  Rahimtoola, Shahbudin H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FOLLOW UP; HEALTH CARE COST; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; NOTE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; CLINICAL TRIALS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 4644234127     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.17.1835     Document Type: Note

References (8)

1. TheMacmillian Dictionary of Quotations: A Unique Reference Combination. Edison, NJ: Chartwell Books Inc; 2000:35-37.
2. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventriculararrhythmias. N Engl J Med. 1997;337: 1576-1583.
3. Moss AJ, Zareba W, Hall JW, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
4. Larsen G, Hallstrom A, McAnulty JH, et al. Cost-effectiveness of the implantable cardioverter-defribillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105:2049-2057.
5. Takaro T, Hultgren HN, Lipton MJ, et al. The VA cooperative randomized study of surgery for coronary arterial occlusive disease, II: subgroup with significant left main lesions. Circulation. 1976;54 (suppl 6):III107-III117.
6. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314:1547-1552.
7. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985:72(6, pt 2):V123-V135.
8. Rahimtoola SH. Bilateral internal mammary artery grafting for coronary artery bypass grafting: why men versus women? Ann Thorac Surg. 2002; 74:1435-1437.